| Literature DB >> 35948869 |
Sam Chidi Ibeneme1,2,3,4,5, Joy Chinyere Eze6, Uchenna Prosper Okonkwo7, Georgian Chiaka Ibeneme8, Gerhard Fortwengel9.
Abstract
BACKGROUND: Systematic reviews demonstrated that gait variables are the most reliable predictors of future falls, yet are rarely included in fall screening tools. Thus, most tools have higher specificity than sensitivity, hence may be misleading/detrimental to care. Therefore, this study aimed to determine the validity, and reliability of the velocity field diagram (VFD -a gait analytical tool), and the Timed-up-and-go test (TUG)-commonly used in Nigeria as fall screening tools, compared to a gold standard (known fallers) among community-dwelling older adults.Entities:
Keywords: Community-dwelling older adults; Discriminatory power; Falls; Reliability; Timed-up-and-go test; Validity; Velocity field diagram
Mesh:
Year: 2022 PMID: 35948869 PMCID: PMC9367093 DOI: 10.1186/s12877-022-03282-2
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 4.070
Fig. 1Design and flow of participants through the study
Biodata, and anthropometric indices for fallers (n = 280) and non-fallers (n = 220)
| Variables | Participants | Non-fallers | Fallers | Mean difference | |
|---|---|---|---|---|---|
| Age (years) | 72.14(4.54) | 70.04(3.76) | 2.10 | 0.35 | |
| Height (cm) | 164.00(6.78) | 160.43(8.13) | 3.57 | 0.10 | |
| Weight (Kg) | 73.00(11.29) | 70.61(17.23) | 2.39 | 0.57 | |
| BMI (Kg/m2) | 25.86(0.23) | 27.58(0.26) | 1.72 | 0.0001** | |
Sex ●Males | 250 (50.0) | 100 (45.45) | 1503.57) | ||
| ●Females | 250 (50.0) | 120 (54.54) | 130 (46.43) | .07 | |
| ●Total | 500 (100.0) | 220 (100) | 280 (100) | ||
Values were expressed as mean (X), standard deviation (SD), number (N) and percentage (%), ** indicates p ≤ 0.0001
Gender distribution of the risk factors for falls among the participants (N = 500)
| Characteristics | Males | Females | Mean difference | Z | |
|---|---|---|---|---|---|
| Fasting blood sugar(mg/dL) | |||||
| ●Fallers & Non-fallers | 102.0 (0.5) | 98.4 (0.5) | 3.6 | < 0.001** | |
| Current smokers/tobacco usersa | |||||
| ●Fallers | 110 | 30 | 7.67 | < .00001**** | |
| ●Non-fallers | 30 | 0 | |||
| 140 (50.0) | 30(10.71) | ||||
| Moderate or higher weekly alcohol intakeb, c | |||||
| ●Fallers | 120 | 40 | 7.97 | < .00001**** | |
| ●Non-fallers | 20 | 10 | |||
| 140 (50.0) | 50 (17.86) | ||||
| Number on anti-anxiety Drugs Medicationc | |||||
| ●Fallers | 90 | 30 | 6.28 | < .00001**** | |
| ●Non-fallers | 40 | 20 | |||
| 130 (46.43) | 50 (17.86) | ||||
| Diabetesa | |||||
| ●Fallers | 60 | 30 | 3.49 | .00048*** | |
| Non-fallers | 30 | 0 | |||
| 90 (32.14 | 30 (10.71 | ||||
| Dizzinessa | |||||
| ●Fallers | 90 | 70 | 1.92 | .055 | |
| Non-fallers | 20 | 10 | |||
| 110 (39.29) | 80 (28.57) | ||||
| Vestibular diseasea | |||||
| ●Fallers | 50 | 20 | 3.87 | .0001*** | |
| Non-fallers | 0 | 0 | |||
| 50 (17.86 | 20 (7.14) | ||||
| Arthritisa | |||||
| ●Fallers | 60 | 80 | -1.99 | .047* | |
| Non-fallers | 20 | 40 | |||
| 80 (28.57) | 120 (42.86) | ||||
Values were expressed as mean (SD) and number (weighted %)
aNumber and percentage
bDefined as weekly alcohol consumption of ≥ 11 units for men and ≥ 8 units for women
cVariable was positively skewed; median and inter-quartile range presente
** indicates p ≤ 0.001
*** indicates p ≤ 0.0001
Basal gait parameters and phases of stride for fallers (n = 280) and non-fallers (n = 220)
| Variables | Velotype 1 | Velotype 2 | Velotype 3 | Velotype 4 | Velotype 5 |
|---|---|---|---|---|---|
| Mean SD | Mean SD | Mean SD | Mean SD | Mean SD | |
| Stride length (m) | |||||
| ●Fallers | 0.56 0.15 | 0.63 0.16 | 0.71 0.15 | 0.83 0.19 | 0.96 0.24 |
| ●Non-fallers | 0.57 0.17 | 0.64 0.18 | 0.72 0.22 | 0.80 0.27 | 0.97 0.29 |
| 0.86 | 0.79 | 0.86 | 0.64 | 0.92 | |
| Stride frequency | |||||
| (strides/s) | |||||
| ●Fallers | 0.58 0.06 | 0.62 0.10 | 0.63 0.16 | 0.80 0.14 | 0.86 0.16 |
| ●Non-fallers | 0.55 0.07 | 0.61 0.12 | 0.64 0.18 | 0.80 0.17 | 0.85 0.17 |
| 0.10 | 0.89 | 0.39 | 1.00 | 0.84 | |
| Velocity (m/s) | |||||
| ●Fallers | 0.31 0.07 | 0.38 0.06 | 0.49 0.08 | 0.66 0.09 | 0.88 0.34 |
| ●Non-fallers | 0.31 0.09 | 0.44 0.14 | 0.50 0.12 | 0.65 0.10 | 0.88 0.39 |
| 0.92 | 0.05a | 0.74 | 0.73 | 1.00 | |
a indicates p < 0.05; Velotype 1 – very slow walking speed; Velotype 2 = slow walking speed; Velotype 3 = normal walking speed; Velotype 4 = fast walking speed; Velotype 5 = very fast walking speed
Fig. 2a The optimal categorizations for discrimination between fallers and non-fallers in relation to sensivity + specify/ TUG times. TUG = Timed-up-and-go-test. b The optimal categorisations for discrimination between fallers and non-fallers in relation to sensitivity and specificity/VFD E1. VFD = Velocity field diagram
Fig.3Velocity field diagram of a faller. 1 = Very slow walking; 2 = slow walking; 3 = normal walking; 4 = fast walking; 5 = very fast walking L-Line = regression line of stride lenth; F-Line = regression line of Stride frequency; V-Line = regression line of velocity; E1 of fallers is 3.5 velots = fall precipitation line
Fig. 4Velocity field Diagram of a non-faller. 1 = Very slow walking; 2 = slow walking; 3 = normal walking; 4 = fast walking; 5 = very fast walking L-Line = regression line of stride length; F-Line = regression line of Stride frequency; V-Line = regression line of velocity; E1 of fallers is 3.5 velots = fall precipitation line
Fig. 5a The evolution of counting-True positive (TP), True negative (TN), False positive (FP), False negative (FN) in relation to thresholds of TUG. TUG = Timed-up-and-go-test. b. The evolution of counting-True positive (TP), True negative (TN), False positive (FP), False negative (FN) in relation to thresholds of VFD E1. VFD = Velocity field diagram
Sensitivity and specificity of the Velocity field diagram and Timed-up-and-go-test in fall prediction among fallers (n = 280) and non-fallers (n = 220)
| 95%CI | ||||||
|---|---|---|---|---|---|---|
| Variable | Non-Fallers | Fallers | Estimated values | Lower limit | Upper limit | Diff CI |
| No. of participants that tested positive | ||||||
| ●VFD | 160(72.7) | 200(71.4) | ||||
| ●TUG | 90(40.9) | 110(39.3) | ||||
| No. of participants that tested negative | ||||||
| ●VFD | 60(27.3) | 80(28.6) | ||||
| ●TUG | 130(59.1) | 170(60.7) | ||||
| Prevalence | 0.56 | 0.41 | 0.70 | 0.29 | ||
| Sensitivity | ||||||
| ●VFD | 0.71 | 0.52 | 0.85 | 0.37 | ||
| ●TUG | 0.39 | 0.22 | 0.59 | 0.37 | ||
| Specificity | ||||||
| ●VFD | 0.20 | 0.57 | 0.37 | |||
| ●TUG | 0.59 | 0.37 | 0.79 | 0.42 | ||
| PPV | ||||||
| ●VFD | 0.56 | 0.83 | 0.26 | |||
| ●TUG) | 0.27 | 0.55 | 0.28 | |||
| NPV | ||||||
| ●VFD | 0.19 | 0.71 | 0.52 | |||
| ●TUG | 0.26 | 0.62 | 0.36 | |||
| Positive[C] | ||||||
| ●VFD | 1.12 | 0.69 | 1.39 | 0.70 | ||
| ●TUG | 0.79 | 0.49 | 1.90 | 1.41 | ||
| Negative[C] | ||||||
| ●VFD | 0.79 | 0.46 | 2.30 | 0.84 | ||
| ●TUG | 1.21 | 0.72 | 1.47 | 0.75 | ||
Fig. 6Compasiron of the AUC of the ROC curves for TUG and VFD. TUG = Timed-up-and-go-test; VFD = Velocity field diagram, AUC = Area under the curve; ROC = Receiver operating characteristics
Comparison of the Area Under the ROC Curve for Velocity field diagram and ‘Timed-Up-and-go test
| tool | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AUC | SE | 95% CI | Difference | z (Observed Value) | p | 95% CI between AUC and 0.5 (Two-tailed test) | ||||
| TUG | 110/280 (39.28%) | 130/220 (59.09%) | 240/500 (48%) | 0.53 | 0.09 | [0.35, 0.70] | 0.03 | 0.30 | 0.76 | [0.147,0.20] |
| VFD | 200/280 (71.42%) | 60/220 (27.27%) | 260/500 (52%) | 0.74 | 0.07 | [0.60, 0.88] | 0.24 | 3.30 | 0.001* | [0.091,0.38] |
* indicates p ≤ 0.001; AUC = Area under the curve; SE = Standard error; 95% CI = 95% confidence interval; z (Critical value) = 1.96
Sensitivity and Specificity of the TUG and VFD for different thresholds
| Screen tool | Sensitivity | Specificity | PPV | NPV | Accuracy |
|---|---|---|---|---|---|
| TUG | |||||
| ≤ 11.77 | 1.00[0.83, 1.00] | 0.09[0.02, 0.29] | 0.52 | 1.00 | 0.60 |
| ≤ 13.25 | 0.54[0.36, 0.70] | 0.36[0.20, 0.57] | 0.46 | 0.44 | 0.46 |
| ≤ 13.72 | 0.36[0.21, 0.54] | 0.64[0.43, 0.80] | 0.50 | 0.50 | 0.48 |
| ≤ 13.98 | 0.18[0.08, 0.36] | 0.82[0.61, 0.93] | 0.50 | 0.50 | 0.46 |
| VFD | |||||
| ≤ 1.80 | 1.00[0.88, 1.00] | 0.00[0.00, 0.18] | 0.50 | 0.00 | 0.56 |
| ≤ 2.57 | 0.86[9.68, 0.95] | 0.23[0.01, 0.44] | 0.51 | 0.57 | 0.56 |
| ≤ 2.93 | 0.75[0.56, 0.88] | 0.32[0.16, 0.53] | 0.52 | 0.56 | 0.56 |
| ≤ 4.05 | 0.39[0.24, 0.58] | 1.00[0.82, 1.00] | 1.00 | 0.62 | 0.66 |
| ≤ 4.29 | 0.18[0.08, 0.36] | 1.00[0.82, 1.00] | 1.00 | 0.55 | 0.54 |
Note. The values in brackets represent 95% confidence intervals. TUG Timed Up and Go Test, VFD Velocity field diagram
Discriminatory ability of the velocity field diagram relative to the reference standard (TUG) tested among fallers (n = 280)
| TUG | ||||||
|---|---|---|---|---|---|---|
| VFD | Test condition | Positive | Negative | Total | Estimated sensitivity of VFD | estimated specificity of VFD |
| Positive | 70 | 130 | 200 | 63.63% | 23.53% | |
| negative | 40 | 40 | 80 | |||
| Total | 110 | 170 | 280 | |||
VFD Velocity diagram; VFD correctly identified 70 of the 110 positive samples, so the estimated sensitivity of VFD is 70/110 × 100% = 63.63%. Four of the 170 negative samples were correctly identified, so the estimated specificity of VFD is 40/170 × 100% = 23.53%.; McNemar test: Pa = 200/280 = 0.7143, Pb = 110/280 = 0.3929, Pa/Pb = 0.3214, p = 0490; odds ratio larger/smaller) = 3.25; 95% CI: 0.97—1.06
Association between E1 and gait speed in male and female
| Model 1 | -0.038 (0.015) | 0.017* | -0.019 (0.017) | 0.172 | ||||
| Model 2 | -0.038 (0.017) | 0.015* | -0.016 (0.016) | 0.278 | ||||
| Model 3 | -0.046 (0.018) | 0.013* | -0.014 (0.018) | 0.372 | ||||
| Model 4 | -0.049 (0.017) | 0.011* | -0.019 (0.014) | 0.369 | ||||
| Model 1 | Q2 v.s. Q1 | -0.017 (0.037) | 0.638 | 0.038* | Q2 v.s. Q1 | 0.049 (0.027) | 0.092 | 0.464 |
| Q3 v.s. Q1 | -0.064 (0.048) | 0.146 | Q3 v.s. Q1 | -0.032 (0.031) | 0.335 | |||
| Q4 v.s. Q1 | -0.078 (0.033) | 0.078 | Q4 v.s. Q1 | -0.001 (0.035) | 0.978 | |||
| Model 2 | Q2 v.s. Q1 | -0.011 (0.055) | 0.790 | 0.056 | Q2 v.s. Q1 | 0.052 (0.027) | 0.075 | 0.531 |
| Q3 v.s. Q1 | -0.059 (0.039) | 0.197 | Q3 v.s. Q1 | -0.025 (0.030) | 0.403 | |||
| Q4 v.s. Q1 | -0.058 (0.034) | 0.078 | Q4 v.s. Q1 | 0.006 (0.038) | 0.908 | |||
| Model 3 | Q2 v.s. Q1 | -0.015 (0.029) | 0.567 | 0.024* | Q2 v.s. Q1 | 0.058 (0.029) | 0.048* | 0.705 |
| Q3 v.s. Q1 | -0.046 (0.031) | 0.120 | Q3 v.s. Q1 | -0.022 (0.033) | 0.508 | |||
| Q4 v.s. Q1 | -0.072 (0.035) | 0.030* | Q4 v.s. Q1 | 0.016 (0.037) | 0.707 | |||
| Model 4 | Q2 v.s. Q1 | -0.008 (0.036) | 0.786 | 0.019* | Q2 v.s. Q1 | 0.052 (0.029) | 0.059 | 0.673 |
| Q3 v.s. Q1 | -0.048 (0.038) | 0.167 | Q3 v.s. Q1 | -0.022 (0.031) | 0.565 | |||
| Q4 v.s. Q1 | -0.063 (0.023) | 0.024* | Q4 v.s. Q1 | 0.009 (0.036) | 0.809 | |||
| Overall Mean | 3.75 ± 1.37 | 3.50 ± 1.25 | 0.25 | 0.044* | ||||
* Indicates p ≤ 0.05,
Adjusted covariates: Model 1 = Age, weight, smoking status, alcohol consumption, and use of walking devices; Model 2 = Model 1 + co-morbidities (dizziness, vestibular diseases, diabetes, and arthritis)
Model 3 = Model 2 + markers of cardiovascular risk (natural-log-transformed levels of the use of anti-anxiety drugs, gender)
Model 4 = Model 3 + BMI categories
* Parameter estimates (β) can be interpreted as differences in mean gait speed (m/sec) for each increment
of one standard deviation in the log-transformed E1 among men (or women)
† Parameter estimates (β) can be interpreted as differences in mean gait speed (m/sec) compared male (or female)
subjects in the 2nd, 3rd, and 4th quartiles of E1 to those in the lowest quartile
Abbreviations: E1 – Equality point for the regression lines of velocity and stride frequency on the VFD; SE, standard error
The cut-off values E1 quartiles among the men were: quartile 1 (< 1.80), quartile 2 (1.80–2.51), quartile 3 (2.52–3.69),
and quartile 4 (> 3.69); while among the women the cut-off values were: quartile 1 (< 1.48), quartile 2 (1.48–2.28),
quartile 3 (2.29–3.52), and quartile 4 (> 3.52)